Changes in blood glucose levels (2A) and body weight (2B) after treatment initiation across the 4 experimental groups (n = 8 per group). (IMAGE)
Caption
CON: Control; DM: Diabetes mellitus; EMPA: Empagliflozin.
Credit
Cardiology Discovery
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND